Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash

Size: px
Start display at page:

Download "Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash"

Transcription

1 Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash Gary M. Reisfield 1, *, Bruce A. Goldberger 1,2, Amadeo J. Pesce 3, Bridgit O. Crews 3, George R. Wilson 4, Scott A. Teitelbaum 1, and Roger L. Bertholf 5 Departments of 1 Psychiatry and 2 Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida; 3 Millennium Research Institute, San Diego, California; and Departments of 4 Community Health and Family Medicine and 5 Pathology, University of Florida Health Science Center, Jacksonville, Florida Abstract To determine the degree of ethanol absorption and the resultant formation and urinary excretion of its conjugated metabolites following intensive use of high ethanol content mouthwash, 10 subjects gargled with Listerine antiseptic 4 times daily for 3¼ days. First morning void urine specimens were collected on each of the four study days and post-gargle specimens were collected at 2, 4, and 6 h after the final gargle of the study. Urine ethanol, ethyl glucuronide (EtG), ethyl sulfate (EtS), and creatinine were measured. Ethanol was below the positive threshold of 20 mg/dl in all of the urine specimens. EtG was undetectable in all pre-study urine specimens, but two pre-study specimens had detectable EtS (6 and 82 ng/ml; 16 and 83 µg/g creatinine). Only one specimen contained detectable EtG (173 ng/ml; 117 µg/g creatinine). EtS was detected in the urine of seven study subjects, but was not detected in the single specimen that had detectable EtG. The maximum EtS concentrations were 104 ng/ml and 112 µg/g creatinine (in different subjects). Three subjects produced a total of eight (non-baseline) urinary EtS concentrations above 50 ng/ml or 50 µg/g creatinine and three EtS concentrations exceeding 100 ng/ml or 100 µg/g creatinine. In patients being monitored for ethanol use by urinary EtG and EtS concentrations, currently accepted EtG and EtS cutoffs of 500 ng/ml are adequate to distinguish between ethanol consumption and four times daily use of high ethanol content mouthwash. Ethanol abstinence is required by substance use monitoring programs for professionals, in certain workplace and legal contexts, and other zero tolerance situations. Measurement of ethanol in breath or body fluids is an insensitive indicator of abstinence because ethanol is rapidly metabolized to acetaldehyde and is detectable in blood and breath for only a few hours after consumption. Ethyl glucuronide (EtG) and ethyl sulfate (EtS) are minor but longer-lasting metabolites of ethanol, and are being used as biomarkers of recent (prior two to five days) ethanol use. However, determining the threshold urinary concentrations of EtG and EtS that reliably distinguish between deliberate ethanol use and incidental exposure to ethanol-containing consumer products (e.g., hand sanitizers, mouthwashes, and food) has been problematic. There is no uniformly applied threshold; laboratories and regulatory authorities (1) have used thresholds from 100 to 1000 ng/ml (2 4). Skipper et al. (5) introduced EtG testing in the United States and have suggested that even a 1000 ng/ml threshold may be too low to rule out incidental ethanol exposures. Indeed, we recently reported a maximum urinary EtG concentration exceeding 2000 ng/ml after intensive handwashing with an ethanol-containing hand sanitizer (6). The aim of this study was to determine the highest concentrations of EtG and EtS that could be produced with frequent, but plausible, use of high ethanol content mouthwash. Introduction * Author to whom correspondence should be addressed: Gary M. Reisfield, MD, University of Florida College of Medicine, 8491 NW 39th Avenue, Gainesville, FL garyr@ufl.edu. Materials and Methods Study protocol The protocol was approved by the University of Florida Institutional Review Board (UFJ ) and informed consent was obtained from all study subjects. Subjects were recruited through personal communications with the investigators. The subjects included six females and four males. Subjects were compensated for their involvement in the study. 264 Reproduction (photocopying) of editorial content of this journal is prohibited without publisher s permission.

2 Study participation was offered to individuals between the ages of 18 and 70, inclusive. Any history of ethanol use disorder, allergy or sensitivity to ethanol, hepatic or renal dysfunction, diabetes mellitus, and symptoms of urinary tract infection were exclusionary criteria. Subjects were required to abstain from ethanol use for five days prior to the study. Instructions included the avoidance of ethanol-containing hand sanitizers and, to as great a degree as possible, ethanol-containing foods, beverages, and cosmetics. Ten subjects were recruited, enrolled, and completed the study. On Day 1 of the study, subjects provided a first morning void urine specimen. Subjects then gargled with 20 ml of Listerine ( Original unflavored product; 26.9% ethanol) antiseptic for 30 s after breakfast, lunch, and dinner, and at bedtime. All subjects subsequently rinsed their mouths with water and expectorated the oral contents. The same procedure was followed on Days 2 and 3. On Day 4, all subjects provided a first morning void urine specimen, gargled after breakfast, and provided urine specimens at 2, 4, and 6 h after this final gargle. All urine specimens were frozen within 30 min of collection. Analytical methods The analytical methods used in this study have been described in a previous publication (6). Briefly, ethanol in urine was measured using the Microgenics DRI Ethyl Alcohol Assay (Microgenics, Fremont, CA) with a lower limit of quantitation of 20 mg/dl; the method is linear to 350 mg/dl. All specimens were screened for EtG using an enzyme immunoassay (DRI EtG, Microgenics); however, all specimens were subjected to confirmatory analysis regardless of the screening result. Creatinine in urine was measured by the DRI Creatinine Specimen Validity Detect Test (Thermo Scientific, Waltham, MA) with a linear range of 0.21 to 350 mg/dl. Creatinine-adjusted EtG and EtS concentrations were based on the conversion of nanogram EtG or EtS per milliliter urine to microgram EtG or EtS per gram of creatinine. EtG and EtS were measured by a liquid chromatography tandem mass spectrometry (LC MS MS) method developed by Millennium Research Institute (San Diego, CA), on an Aria Transcend multiplexing LC system paired with a Quantum Ultra triple-stage quadrupole MS and Xcalibur software (Thermo Scientific). The details of the LC MS MS method have been previously published (7). The selectivity of the method was assessed against a library of approximately 100 drugs and metabolites, and no interference was observed. Day-to-day coefficients of variation of the EtG assay were 8% and 3% at 625 and 1250 ng/ml, respectively, and 7% at 200 ng/ml for the EtS assay, using quantitative values from three independent batches per day obtained over five days. Day-to-day coefficients of variation were 7% and 4% for the EtG and EtS assays, respectively, at their lower limits of quantitation. The analytical performance characteristics for the EtG and EtS confirmatory assays are summarized in Table I. Results Urine EtG, EtS, and creatinine results are presented in Table II. None of the subjects had detectable EtG in their urine at the beginning of the study, although two had detectable concentrations of EtS (6 and 82 ng/ml; 16 and 83 µg/g creatinine). Ethanol concentrations in all specimens were below the quantitation threshold of 20 mg/dl. Among all specimens, only one had a detectable concentration of EtG (173 ng/ml; 117 µg/g creatinine); this single specimen was a 2-h post-gargle specimen on the final day of the study. EtS was detected in the urine of 7 of the 10 participants, but it was not detected in the single specimen with detectable EtG. The maximum EtS concentration detected was 104 ng/ml (or 112 µg/g creatinine, in another subject). Three of the 10 subjects produced a total of 8 urinary EtS concentrations above 50 ng/ml, and 10 specimens exceeded 50 µg/g creatinine. Three specimens had EtS concentrations exceeding 100 ng/ml. Screening immunoassays were imperfect predictors of urinary EtG concentrations in this study. At a screening threshold of 100 ng/ml, one of the specimens screened negative for EtG, but yielded an EtG concentration of 173 ng/ml measured by LC MS MS. Two specimens produced screening results above the screening threshold (221 and 13,622 ng/ml) but did not yield detectable EtG concentrations by LC MS MS. Table I. Performance of the EtG and EtS Methods* EtG EtS Method LC MS MS LC MS MS Linear range ,000 ng/ml ,000 ng/ml Interday precision (% CV) 7% 4% Interday accuracy (% Bias) 11% 7% * The accuracy of the assays were determined by quantitation of EtG and EtS in quality control samples prepared in synthetic urine at concentrations of 750 ng/ml for EtG and 200 ng/ml for EtS. Interday precision and bias were determined by repeating the assay (n = 20). EtS linearity and bias were also assessed between 10 and 100 ng/ml. The average bias for urine specimens containing 10 ng/ml EtS was 23%, and it was less than 20% at 50, 70, and 100 ng/ml. Discussion There are innumerable environmental sources of incidental ethanol exposure, many of which have been shown to produce appreciable quantities of urinary ethanol metabolites. Several investigators have reported urinary concentrations of EtG and EtS after intensive use of ethanol-containing hand sanitizers. Reisfield et al. (6) recently demonstrated peak urinary EtG and EtS concentrations of 2001 ng/ml (1998 µg/g creatinine) and 83 ng/ml (94 µg/g creatinine), respectively, following intensive use of ethanol (62%)-containing hand sanitizer. Musshoff et al. (1) recently reported measurable quantities of ethanol in a variety of foods and beverages. This German study found peak urinary EtG concentrations of 512 ng/ml following 265

3 Table II. Summary of Data Obtained for Urinary EtG, EtS, and Creatinine EtG EtS Creatinine EtG EtS (ng/ml) (ng/ml) (mg/dl) µg/g creatinine µg/g creatinine Subject 1 A* B C D E F G Subject 2 A B C D E F G Subject 3 A B C D E F G Subject 4 A B C D E F G Subject 5 A B C D E F G Subject 6 A B C D E F G * A: pre-exposure morning void, day 1; B: first void, study day 2; C: first void, study day 3; D: first void, study day 4; E: day 4, 2 h after final mouthwash; F: day 4, 4 h after final mouthwash; and G: day 4, 6 h after final mouthwash. (See Study Protocol in Materials and Methods.) the consumption of 2 3 L of nonalcoholic beer (ethanol content: 3.6 g/l), peak EtS concentrations of 648 ng/ml following consumption of up to 2 L of grape juice (ethanol content: 1.25 g/l), peak EtG concentrations of 200 ng/ml following consumption of 750 g of sauerkraut (ethanol content: 2 g/kg), and peak EtG concentrations of 120 ng/ml following consumption of g of ripe bananas (ethanol content: 5 g/kg). In the case of the nonalcoholic beer, EtG was detectable for up to 7 and 13 h at cutoffs of 500 and 100 ng/ml, respectively. Current EtG and EtS cutoffs for distinguishing ethanol consumption from incidental exposures are non-uniform, empirically derived, and have been vigorously debated (8,9). We identified two peer-reviewed articles that examined urinary ethanol and metabolites after use of ethanol-containing mouthwash. In the first, Costantino et al. (10) performed a twopart study. In the first part, nine subjects provided a baseline (pre-exposure) urine specimen, which was required to be negative for ethanol and EtG. Subjects then gargled with a mouthful of Cepacol (12% ethanol) mouthwash for 30 s and repeated this until the entire 4-oz. bottle had been used. All gargling was completed over a 15-min period. Multiple urine specimens (two to seven) were collected over the following 24 h, and all specimens were refrigerated within 1 h of collection. Eight of the nine subjects produced at least one urine specimen with detectable EtG. The maximum EtG was 345 ng/ml (227 µg/g creatinine), obtained 90 min after gargling. Omitted from the data and discussion was the fact that the maximum corrected EtG was 790 µg/g creatinine, obtained 74 min after exposure. In the second part of the study, 11 subjects gargled with Cepacol mouthwash three times daily for five days. The first morning void urine was collected each day. Eight of the 11 subjects produced at least one EtG-positive urine. Sixteen of the 66 specimens (and of the 55 non-baseline specimens) had detectable EtG at a cutoff of 50 ng/ml. The maximum EtG concentration was 108 ng/ml on the final morning void of one subject. Urine creatinine concentrations for this part of the study were not reported. In another study, Høiseth et al. (11) ex- 266

4 amined urinary, blood, and oral fluid concentrations of ethanol, EtG, and EtS following the use of mouthwash, nonalcoholic wine, or 3.75 ml of vodka. Four subjects rinsed their mouths with 15 ml of Listerine mouthwash (21.6% ethanol) for eight cycles of rinsing for 1 min followed by resting for 30 s. Urine samples were collected at 1.5, 3.5, 5.5, and 7.5 h after use of mouthwash. Ethanol, tested by an enzymatic method, was undetectable in all urine samples. EtG and EtS, measured by LC MS MS, were undetectable in all samples at the LOD and LOQ of 170 and 370 ng/ml, respectively. A non-peer-reviewed publication included a study involving two subjects given intensive exposure to mouthwash (12). Subjects used 20 ml of Target Springmint Antiseptic Mouth Table II (continued). Summary of Data Obtained for Urinary EtG, EtS, and Creatinine EtG EtS Creatinine EtG EtS (ng/ml) (ng/ml) (mg/dl) µg/g creatinine µg/g creatinine Subject 7 A* B C D E F G Subject 8 A B C D E F G Subject 9 A B C D E F G Subject 10 A B C D E F G * A: pre-exposure morning void, day 1; B: first void, study day 2; C: first void, study day 3; D: first void, study day 4; E: day 4, 2 h after final mouthwash; F: day 4, 4 h after final mouthwash; and G: day 4, 6 h after final mouthwash. (See Study Protocol in Materials and Methods.) Rinse (21.6% ethanol), swished between the teeth for 30 s, hourly for 8 h. Urine specimens were collected at 2, 4, 6, 8, and 16 h (first next-morning void). EtG and EtS measurements were made by LC MS MS at the detection limits of 37.8 and 7.2 ng/ml, respectively. A maximum urinary EtG concentration of 366 ng/ml (194 µg/g creatinine) was measured in one of the subjects 6 h after exposure. The maximum urinary EtS concentration was 73 ng/ml (41 µg/g creatinine) in the same subject 8 h following exposure. Our work differs from previous studies in several respects. First, we used mouthwash with the highest available ethanol content (26.9%). Second, subjects gargled with the mouthwash rather than merely swishing it between their teeth. Third, four times daily gargling (twice the recommended frequency), rather than gargling a large volume over a short period of time, simulates realistic use of mouthwash. Notwithstanding these differences, our study mostly confirms and extends the findings of others. Specifically, intensive but plausible mouthwash use does not yield urinary ethanol at the quantifiable limit of 20 mg/dl, and does not produce raw or corrected urinary EtG or EtS concentrations in excess of 200 ng/ml or 200 µg/g creatinine. As in our previous study of dermal exposure to ethanol-containing hand sanitizer (6), small quantities of ethanol were detected below the quantifiable limit of 20 mg/dl. Precision studies with ethanolfree controls, however, revealed that some of the measured urinary ethanol concentrations were slightly above a 99% statistical threshold for background noise using the enzymatic ethanol assay. We suspect that the very low detectable concentrations of urinary ethanol were likely due to oropharyngeal mucosal absorption, inadvertent swallowing with subsequent gastrointestinal uptake, and/or endogenous production of ethanol. In agreement with the studies performed by Costantino et al. (10), Høiseth et al. (11), and Jones et al. (12), our results do not demonstrate any apparent accumulation of EtG. Likewise, in agreement with the data in Jones and coworkers study (12), we found no evidence of daily accumulation of EtS. An EtG and EtS threshold of at least 500 ng/ml is adequate to distinguish between intentional ethanol use and incidental exposure caused by intensive use of high alcohol content mouthwash. Use of a threshold at 100 or 200 ng/ml has a potential for false-positive results in patients who regularly use mouthwash. 267

5 Conclusions Four-times-daily exposure to high ethanol content mouthwash produced maximum urinary EtG concentrations of 173 ng/ml (117 µg/g creatinine) and maximum EtS concentrations of 104 ng/ml (112 µg/g creatinine). Ethanol was not detected in any specimen at the quantifiable limit of 20 mg/dl. The urinary concentrations of EtG and EtS measured in this study were well below the commonly accepted (United States) threshold of 500 ng/ml for evidence of deliberate ethanol ingestion. This confirms and extends previous work that ethanolcontaining mouthwash does not result in metabolite concentrations that exceed 500 ng/ml or 500 µg/g creatinine. These data, which reflect urinary ethanol metabolite concentrations under circumstances that simulate reasonable scenarios for intensive use of mouthwash, demonstrate that such use is unlikely to produce urinary ethanol metabolite concentrations that, by current standards, may be interpreted as ethanol consumption. References 1. F. Musshoff, E. Albermann, and B. Madea. Ethyl glucuronide and ethyl sulfate in urine after consumption of various beverages and foods misleading results? Int. J. Legal Med. 124: (2010). 2. A Thierauf, A. Wohlfarth, V. Auwärter, M.G. Perdekamp, F.M. Wurst, and W. Weinmann. Urine tested positive for ethyl glucuronide and ethyl sulfate after the consumption of yeast and sugar. Forensic Sci. Int. 202: e45 e47 (2010). 3. A. Thierauf, C.C. Halter, S. Rana, V. Auwaerter, A. Wohlfarth, F.M. Wurst, and W. Weinmann. Urine tested positive for ethyl glucuronide after trace amounts of ethanol. Addiction 104: (2009). 4. A. Thierauf, H. Gnann, A. Wohlfarth, V. Auwärter, M.G. Perdekamp, K.J. Buttler, F.M. Wurst, and W. Weinmann. Urine tested positive for ethyl glucuronide and ethyl sulphate after the consumption of non-alcoholic beer. Forensic Sci. Int. 202: (2010). 5. G.E. Skipper, W. Weinmann, A. Thierauf, P. Schaefer, G. Wiesbeck, J.P. Allen, M. Miller, and F.M. Wurst. Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcohol. 39: (2004). 6. G.M. Reisfield, B.A. Goldberger, B.O. Crews, A.J. Pesce, G.R. Wilson, S.A. Teitelbaum, and R.L. Bertholf. Ethyl glucuronide, ethyl sulfate, and ethanol in urine after sustained exposure to an ethanol-based hand sanitizer. J. Anal. Toxicol. 35: (2011). 7. B. Crews, S. Latyshev, C. Mikel, P. Almazan, R. West, A. Pesce, and C. West. Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC MS/MS. J. Opioid Manag. 6(6): (2010). 8. K. Helliker. A test for alcohol and its flaws. Wall Street Journal, August 12, S.B. Karch. Ethanol-based hand cleansers. J. Forensic Leg. Med. 16: (2009). 10. A. Costantino, E.J. Digregorio, W. Korn, S. Spayd, and F. Rieders. The effect of the use of mouthwash on ethylglucuronide concentrations in urine. J. Anal. Toxicol. 30: (2006). 11. G. Høiseth, B. Yttredal, R. Karinen, H. Gjerde, and A. Christophersen. Levels of ethyl glucuronide and ethyl sulfate in oral fluid, blood, and urine after use of mouthwash and ingestion of nonalcoholic wine. J. Anal. Toxicol. 34: (2010). 12. J.T. Jones, M.R. Jones, C.A. Plate, and D. Lewis. Ethyl glucuronide and ethyl sulfate concentrations following use of ethanol containing mouthwash. whitepapers_etgmouthwash_fd_ pdf (accessed November 2010). Manuscript received November 22, 2010; revision received January 16,

Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Sustained Exposure to an Ethanol-Based Hand Sanitizer

Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Sustained Exposure to an Ethanol-Based Hand Sanitizer Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Sustained Exposure to an Ethanol-Based Hand Sanitizer Gary M. Reisfield 1, *, Bruce A. Goldberger 1,2, Bridgit O. Crews 3, Amadeo J. Pesce 3,

More information

Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair

Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair Submission by Bozzo Andrea mobile: +393401932599 e-mail: andrea2bozzo@gmail.com Introduction The

More information

2/12/2019. Direct biomarkers of alcohol consumption in professionals health programs. Objectives. IPN/PRN Annual Conference and Evaluator Training

2/12/2019. Direct biomarkers of alcohol consumption in professionals health programs. Objectives. IPN/PRN Annual Conference and Evaluator Training IPN/PRN Annual Conference and Evaluator Training Direct biomarkers of alcohol consumption in professionals health programs Scott A. Teitelbaum, M.D. Gary M. Reisfield, M.D. Division of Addiction Medicine

More information

EtG/EtS in Urine from Sexual Assault Victims Determined by UPLC MS-MS

EtG/EtS in Urine from Sexual Assault Victims Determined by UPLC MS-MS Journal of Analytical Toxicology 2013;37:227 232 doi:10.1093/jat/bkt008 Advance Access publication March 6, 2013 Article EtG/EtS in Urine from Sexual Assault Victims Determined by UPLC MS-MS Solfrid Hegstad

More information

Levels of Ethyl Glucuronide and Ethyl Sulfate in Oral Fluid, Blood, and Urine After Use of Mouthwash and Ingestion of Nonalcoholic Wine

Levels of Ethyl Glucuronide and Ethyl Sulfate in Oral Fluid, Blood, and Urine After Use of Mouthwash and Ingestion of Nonalcoholic Wine Levels of Ethyl Glucuronide and Ethyl Sulfate in Oral Fluid, Blood, and Urine After Use of Mouthwash and Ingestion of Nonalcoholic Wine Gudrun Høiseth*, Borghild Yttredal, Ritva Karinen, Hallvard Gjerde,

More information

S t r a i g h t T o x

S t r a i g h t T o x S t r a i g h t T o x Ethanol, Ethyl Glucuronide, and Ethyl Sulfate in Urine by Dwain Fuller, D-FTCB, TC-NRCC Over the past couple of years I have found myself increasingly involved in interpreting the

More information

ASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification

ASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification Alcohol & Alcoholism Vol. 44, No., pp. 55 6, 2009 Advance Access publication 29 October 2008 doi:.93/alcalc/agn084 ASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate

More information

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections *

Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections * Identifying New Cannabis Use with Urine Creatinine- Normalized THCCOOH Concentrations and Time Intervals Between Specimen Collections * Michael L. Smith 1, Allan J. Barnes 2, and Marilyn A. Huestis 2,

More information

ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS

ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS FORENSICS AND TOXICOLOGY ANALYSIS ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS Solutions for Your Analytical Business Markets

More information

A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri

A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring 2012 By: Paul L. Cary Toxicology Laboratory University of Missouri A bit of history: September 25, 2006, the U.S. Department

More information

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L.

Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L. Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity Alessandro Federico University of Campania L. Vanvitelli Alessandro Federico Markers of Alcohol Abuse in Alcoholic Liver

More information

Review Article. Ethyl glucuronide. Natalie E Walsham 1 and Roy A Sherwood 2

Review Article. Ethyl glucuronide. Natalie E Walsham 1 and Roy A Sherwood 2 Review Article Ethyl glucuronide Natalie E Walsham 1 and Roy A Sherwood 2 1 Department of Clinical Biochemistry, University Hospital Lewisham, High Street, Lewisham, London SE13 6LH; 2 Department of Clinical

More information

Ethyl Sulfate: A Metabolite of Ethanol in Humans and a Potential Biomarker of Acute Alcohol Intake

Ethyl Sulfate: A Metabolite of Ethanol in Humans and a Potential Biomarker of Acute Alcohol Intake Ethyl Sulfate: A Metabolite of Ethanol in Humans and a Potential Biomarker of Acute Alcohol Intake Anders Helander 1,* and Olof Beck 2 1Department of Clinical Neuroscience and 2Department of Medicine,

More information

Best Practices Review Drug & EtG/EtS Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant

Best Practices Review Drug & EtG/EtS Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant Best Practices Review Drug & EtG/EtS Testing By: Paul L. Cary Independent Forensic Toxicology Consultant Reasons for Drug Testing - WHY? act as a deterrent to future drug use identify participants who

More information

Higher levels of hair EtG in patients with decreased kidney function.

Higher levels of hair EtG in patients with decreased kidney function. MD Jan Toralf Fosen 1, PhD Gudrun Høiseth 1, Ph.D Luca Morini 2, Prof. Jørg Mørland 1. 1 Norwegian Institute of Public Health, Division of forensic medicine and drug abuse research, Oslo, Norway. 2 Department

More information

ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 39, No. 5 May 2015

ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 39, No. 5 May 2015 ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 39, No. 5 May 2015 Determining Ethyl Glucuronide Cutoffs When Detecting Self-Reported Alcohol Use in Addiction Treatment Patients Jessica M. Lowe, Michael

More information

Jennifer P. Pascali, PhD. dtolabs, Resana (TV)

Jennifer P. Pascali, PhD. dtolabs, Resana (TV) Jennifer P. Pascali, PhD dtolabs, Resana (TV) Agilent Technologies Users Meeting, 20 May 2014 The project dtolabs dtolabs is an analytical research centre founded by two leading companies in the production

More information

SmartNotes. Thermo Scientific Specimen Validity Tests for Drugs of Abuse Testing

SmartNotes. Thermo Scientific Specimen Validity Tests for Drugs of Abuse Testing DIAGNOSTICS s SmartNotes Thermo Scientific s for Drugs of Abuse ing for Urine Tampering Using s Urine is the most commonly used specimen for drugs of abuse testing. This is primarily because urine is readily

More information

Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets)

Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets) International Journal of Emergency Mental Health and Human Resilience, Vol. 19, No.3, pp. 1, ISSN 1522-4821 Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets) Abuelgasim

More information

Harmless, minimal alcohol content

Harmless, minimal alcohol content Harmless, minimal alcohol content 1. Study of forensic medicine institute 2. Alcohol-free signal 3. Alcohol content of common foodstuffs 4. Questions and answers 1. Study of forensic medicine institute

More information

Adulterated Diluted samples will be treated as a Drug Court Sanction.

Adulterated Diluted samples will be treated as a Drug Court Sanction. Drug Court Participant, TESTING INFORMATION / PARTICIPANT AGREEMENT Each participant will be required to submit to random urine testing, while in the Drug Court Program. It is in your best interest to

More information

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS FORENSICS AND TOXICOLOGY ANALYSIS DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS Solutions for Your Analytical Business Markets and Applications

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Forensic Toxicology. Forensic Science

Forensic Toxicology. Forensic Science Forensic Toxicology Forensic Science Copyright and Terms of Service Copyright Texas Education Agency, 2011. These materials are copyrighted and trademarked as the property of the Texas Education Agency

More information

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system Xiang He 1, Adrian Taylor 2 and Alexandre Wang 1 1 SCIEX, Redwood City, USA. 2 SCIEX, Concord,

More information

The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study

The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study Kenneth Edgell 1, Yale H. Caplan 2, Leon R. Glass 3, and Janine Denis Cook 4 1U.S. Department of Transportation,

More information

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring and in Urine Xiaolei Xie, Joe DiBussolo, Marta Kozak; Thermo Fisher Scientific, San Jose, CA Application Note 627 Key Words, norbuprenorphine,

More information

Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption?

Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Miscellaneous Ethyl glucuronide in hair and alcohol consumption Lucia Politi et al. METHODS AND TECHNIQUES doi:10.1111/j.1360-0443.2006.01537.x Ethyl glucuronide in hair: is it a reliable marker of chronic

More information

Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1

Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1 Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1 Paul R. Marques Pacific Institute for Research and Evaluation 11720 Beltsville Dr., Suite 900,

More information

RELIABILITY AND VALIDITY OF BLOOD ALCOHOL CONCENTRATION RELATED TO MEASURED PERFORMANCE DECREMENT

RELIABILITY AND VALIDITY OF BLOOD ALCOHOL CONCENTRATION RELATED TO MEASURED PERFORMANCE DECREMENT RELIABILITY AND VALIDITY OF BLOOD ALCOHOL CONCENTRATION RELATED TO MEASURED PERFORMANCE DECREMENT Gene G. Rugotzke, Wyoming Public Health Laboratory, Cheyenne, Wyoming, U.S.A.; Robert L. Wilkes, and Robert

More information

The effects of zinc sulfate on ethyl glucuronide immunoassay urine testing

The effects of zinc sulfate on ethyl glucuronide immunoassay urine testing Boston University OpenBU Theses & Dissertations http://open.bu.edu Boston University Theses & Dissertations 2016 The effects of zinc sulfate on ethyl glucuronide immunoassay urine testing Cawley, Shanna

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

Therapeutics & Toxins News Newsletter for the TDM and Toxicology Division of AACC

Therapeutics & Toxins News Newsletter for the TDM and Toxicology Division of AACC Therapeutics & Toxins News Newsletter for the TDM and Toxicology Division of AACC In This Issue: Phencyclidine false positive Editor s Corner: Division Activities in AACC National Meeting 2015 Phencyclidine

More information

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided Opiates Rapid Test Cat. No.:DTS137 Pkg.Size:50T Intended use The CD One Step Opiates Screening Test is a rapid, qualitative immunoassay for the detection of opiates and opiate metabolites in urine. The

More information

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS

Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS Quantitative Method for Amphetamines, Phentermine, and Designer Stimulants Using an Agilent 6430 LC/MS/MS Application Note Forensic Toxicology Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca

More information

Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1

Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1 Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1 Paul R. Marques 1 A. Scott Tippetts 1 Michel Yegles 2 1 Pacific Institute for Research and Evaluation 11720

More information

Illicit Drug Use Correlates with Negative Urine Drug Test Results for Prescribed Hydrocodone, Oxycodone, and Morphine

Illicit Drug Use Correlates with Negative Urine Drug Test Results for Prescribed Hydrocodone, Oxycodone, and Morphine Pain Physician 2012; 15:E687-E692 ISSN 2150-1149 Retrospective Evaluation Illicit Drug Use Correlates with Negative Urine Drug Test Results for Prescribed Hydrocodone, Oxycodone, and Morphine Amadeo Pesce,

More information

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management bs_bs_banner Pain Medicine 2013; 14: 1813 1820 Wiley Periodicals, Inc. PROFESSIONALISM AND COMMENTARY Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management Disclosure: The

More information

BEFORE THE MEDICAL BOARD OF CALIFORNIA DEPARTMENT OF CONSUMER AFFAIRS STATE OF CALIFORNIA. OAH No DECISION

BEFORE THE MEDICAL BOARD OF CALIFORNIA DEPARTMENT OF CONSUMER AFFAIRS STATE OF CALIFORNIA. OAH No DECISION BEFORE THE MEDICAL BOARD OF CALIFORNIA DEPARTMENT OF CONSUMER AFFAIRS STATE OF CALIFORNIA In the Matter of the Petition to Revoke Probation Against: LUIS PHILIP NUGENT, M.D. Physician's and Surgeon's Certificate

More information

8.7 How Breathalysers Work. Grade 8 Activity Plan

8.7 How Breathalysers Work. Grade 8 Activity Plan 8.7 How Breathalysers Work Grade 8 Activity Plan 1 8.7 How Breathalysers Work Objectives: 1. To understand the physiological implications and social consequences of increased blood alcohol concentration

More information

Alcohol Biomarkers. BMF 77 - Alcohol Biomarkers

Alcohol Biomarkers. BMF 77 - Alcohol Biomarkers Alcohol Biomarkers BMF 77 - Alcohol Biomarkers Self-reporting of alcohol consumption is objective and inherently unreliable. This has led to an intensive search for a reliable marker of chronic, excessive

More information

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED:

Payment Policy Drug Testing EFFECTIVE DATE: POLICY LAST UPDATED: Payment Policy Drug Testing EFFECTIVE DATE: 05 23 2013 POLICY LAST UPDATED: 06 05 2018 OVERVIEW This policy documents the criteria and documentation requirements for immunoassay (IA) testing (also called

More information

Drug Testing: How to Evaluate Results

Drug Testing: How to Evaluate Results Drug Testing: How to Evaluate Results Prepared for you by the West Virginia Drug Testing Laboratory Drug testing, whether for an individual or a large corporation, consists of two necessary steps - specimen

More information

Introduction. Ahmed I. Al-Asmari 1,2, *, Robert A. Anderson 1, and Patrik Appelblad 3 1. Abstract

Introduction. Ahmed I. Al-Asmari 1,2, *, Robert A. Anderson 1, and Patrik Appelblad 3 1. Abstract Direct Determination of Ethyl Glucuronide and Ethyl Sulfate in Postmortem Urine Specimens Using Hydrophilic Interaction Liquid Chromatography Electrospray Ionization-Tandem Mass Spectrometry * Ahmed I.

More information

Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum

Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum NINA KANGAS, SIRPA MYKKÄNEN, SANNA KYLLÖNEN, PÄIVI RAJALA, KARI ARINIEMI

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Cutoff levels for hydrocodone in a blood test

Cutoff levels for hydrocodone in a blood test Cutoff levels for hydrocodone in a blood test The premier DNA and drug testing company in the North Texas area. Specializing in legal cases but also provide testing for employers and private individuals.

More information

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System

Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Application Note Forensics, Workplace Drug Testing Detection of Cannabinoids in Oral Fluid with the Agilent 7010 GC-MS/MS System Authors Fred Feyerherm and Anthony Macherone Agilent Technologies, Inc.

More information

HAIR ALCOHOL TESTING EtG

HAIR ALCOHOL TESTING EtG HAIR ALCOHOL TESTING EtG HAIR ALCOHOL TESTING (EtG) A test that measures average alcohol consumption over a period of approximately three months, indicates the level of alcohol use during that time period,

More information

Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000

Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000 Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000 Amitava Dasgupta, Ph.D Professor of Pathology and Laboratory Medicine University of Texas Medical School at Houston Disclosure

More information

Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2

Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2 Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2 A.W. Jones and KÄ. Jönsson Departments of Alcohol Toxicology and Internal Medicine, University Hospital,

More information

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

A High-throughput Mass Spectrometry Multiplexed Assay to Measure Insulin and C- peptide

A High-throughput Mass Spectrometry Multiplexed Assay to Measure Insulin and C- peptide A High-throughput Mass Spectrometry Multiplexed Assay to Measure Insulin and C- peptide Steven W. Taylor 1, Zhaohui Chen 1,2, Richard E. Reitz 1, Michael J. McPhaul 1, Nigel J. Clarke 1 1 Quest Diagnostics

More information

A Toxicologists View of Addiction

A Toxicologists View of Addiction A Toxicologists View of Addiction Deborah Motika, MS, MS, TC(NRCC) Senior Vice President, Toxicologist AGENDA Background : Addiction Toxicology 101 Drug testing 101 Question and Answer Session 2 ADDICTION

More information

Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance

Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance Pain Physician 2017; 20:E1107-E1113 ISSN 2150-1149 Retrospective Study Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance Kevin Krock, PhD, Amadeo Pesce, PhD, Dennis Ritz,

More information

2.1 Determination of Ethanol (Ethyl Alcohol)

2.1 Determination of Ethanol (Ethyl Alcohol) Document #: 4981 Page 1 of 13 2.1 Determination of Ethanol (Ethyl Alcohol) 2.1.1 General Description of Method A procedure utilizing a gas chromatograph (GC) for the determination of ethanol. Two quantitative

More information

Interpretation of Pain Management Testing Results Using Case Examples

Interpretation of Pain Management Testing Results Using Case Examples Interpretation of Pain Management Testing Results Using Case Examples Philip M. Sobolesky, 1 * Breland E. Smith, 1 Amadeo J. Pesce, 2 and Robert L. Fitzgerald 1 Background: Because of the increasing volume

More information

Relapse of alcohol consumption occurs in

Relapse of alcohol consumption occurs in Urinary Ethyl Glucuronide as a Novel Screening Tool in Patients Pre- and Post Liver Transplantation Improves Detection of Alcohol Consumption Katharina Staufer, 1 * Hilke Andresen, 2 * Eik Vettorazzi,

More information

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Toxicology 101. Arizona Problem Solving Courts April 25, 2016 Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is

More information

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics Quantitative Analysis of piates in Urine Using RRHT LC/MS/MS Application Forensics Authors Sheher Mohsin Agilent Technologies, Inc. 10 N. Martingale Rd., Suite 550 Schaumburg, IL 60173 USA Yanan Yang Agilent

More information

Ethyl sulfate (EtS) is a newly discovered direct

Ethyl sulfate (EtS) is a newly discovered direct APPLICATION NOTE Forensic Confirmatory Analysis of Ethyl Sulfate A New Marker for Alcohol Consumption by Liquid-Chromatography/ Electrospray Ionization/Tandem Mass Spectrometry Sebastian Dresen and Wolfgang

More information

Potential adulterating capabilities of commercial zinc products on preliminary immunoassay screenings for the detection of ethyl glucuronide (ETG)

Potential adulterating capabilities of commercial zinc products on preliminary immunoassay screenings for the detection of ethyl glucuronide (ETG) Boston University OpenBU Theses & Dissertations http://open.bu.edu Boston University Theses & Dissertations 2017 Potential adulterating capabilities of commercial zinc products on preliminary immunoassay

More information

Simple Cancer Screening Based on Urinary Metabolite Analysis

Simple Cancer Screening Based on Urinary Metabolite Analysis FEATURED ARTICLES Taking on Future Social Issues through Open Innovation Life Science for a Healthy Society with High Quality of Life Simple Cancer Screening Based on Urinary Metabolite Analysis Hitachi

More information

James Grech. Bachelor of Medical Science (UC) National Centre for Forensic Studies (NCFS) University of Canberra, ACT 2601

James Grech. Bachelor of Medical Science (UC) National Centre for Forensic Studies (NCFS) University of Canberra, ACT 2601 Evaluation of Enzyme-Linked ImmunoSorbent Assay and Liquid Chromatography-Tandem Mass Spectrometry as Screening and Confirmation Methods for the Detection of Synthetic Cannabinoids James Grech Bachelor

More information

IDEXX Catalyst SDMA Test for in-house measurement of SDMA concentration in serum from dogs and cats

IDEXX Catalyst SDMA Test for in-house measurement of SDMA concentration in serum from dogs and cats IDEXX Catalyst SDMA Test for in-house measurement of SDMA in serum from dogs and cats By Graham Bilbrough, Barbara Evert, Karen Hathaway, Gina Panagakos, Jane Robertson, and Maha Yerramilli Introduction

More information

Forensic Drug Testing for Opiates. VII. Urinary Excretion Profile of Intranasal (Snorted) Heroin

Forensic Drug Testing for Opiates. VII. Urinary Excretion Profile of Intranasal (Snorted) Heroin Journal of Analytical Toxicology, Vol, 20, October ] 996 Forensic Drug Testing for Opiates. VII. Urinary Excretion Profile of Intranasal (Snorted) Heroin Edward J. Cone*, Rebecca Jufer, and William D.

More information

1D Proton NMR Spectroscopic Determination of Ethanol and Ethyl Glucuronide in Human Urine

1D Proton NMR Spectroscopic Determination of Ethanol and Ethyl Glucuronide in Human Urine Determination of Ethanol Ingestion Bull. Korean Chem. Soc. 2013, Vol. 34, No. 8 2413 http://dx.doi.org/10.5012/bkcs.2013.34.8.2413 1D Proton NMR Spectroscopic Determination of Ethanol and Ethyl Glucuronide

More information

Prior to making any insulin adjustments the following knowledge and skills are required:

Prior to making any insulin adjustments the following knowledge and skills are required: Diabetes Control Diabetes Control Food, activity and insulin influence your blood glucose levels. At times it may seem like a juggling act as you attempt to balance these three factors. Home blood glucose

More information

IDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats

IDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats IDEXX Catalyst One Chemistry Analyzer for In-house Measurement of Total Thyroxine (TT 4 ) Concentration in Serum from Dogs and Cats Authors: Kate Cote, Ph.D., Graham Bilbrough, MA, VetMB, CertVA, MRCVS,

More information

NIH Public Access Author Manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2011 March 1.

NIH Public Access Author Manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2011 March 1. NIH Public Access Author Manuscript Published in final edited form as: Alcohol Clin Exp Res. 2010 March 1; 34(3): 488 492. doi:10.1111/j.1530-0277.2009.01113.x. Phosphatidylethanol and Alcohol Consumption

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation,

More information

OneStep Barbiturates Urine RapiCard InstaTest. Cat. # FOR THE QUALITATIVE ASSESSMENT OF BARBITURATE IN HUMAN URINE

OneStep Barbiturates Urine RapiCard InstaTest. Cat. # FOR THE QUALITATIVE ASSESSMENT OF BARBITURATE IN HUMAN URINE CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label Σ=25

More information

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department

More information

BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY

BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY BENZODIAZEPINE FINDINGS IN BLOOD AND URINE BY GAS CHROMATOGRAPHY AND IMMUNOASSAY Ilpo RASANEN, Mikko NEUVONEN, Ilkka OJANPERÄ, Erkki VUORI Department of Forensic Medicine, University of Helsinki, Helsinki,

More information

Medical Policy Outpatient Drug Screening and Testing. No Prior Authorization X X

Medical Policy Outpatient Drug Screening and Testing. No Prior Authorization X X Medical Policy Outpatient Drug Screening and Testing Document Number: 030 Authorization required Commercial and Qualified Health Plans MassHealth No Prior Authorization X X Overview The purpose of this

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

A New Highly Specific Buprenorphine Immunoassay for Monitoring Buprenorphine Compliance and Abuse

A New Highly Specific Buprenorphine Immunoassay for Monitoring Buprenorphine Compliance and Abuse Journal of Analytical Toxicology 2012;36:201 206 doi:10.1093/jat/bks003 Article A New Highly Specific Buprenorphine Immunoassay for Monitoring Buprenorphine Compliance and Abuse Stacy E.F. Melanson 1 *,

More information

Detection of Cotinine and 3- hydroxycotine in Smokers Urine

Detection of Cotinine and 3- hydroxycotine in Smokers Urine Detection of Cotinine and 3- hydroxycotine in Smokers Urine Behavioural and Situational Research Group School of Medicine, University of Tasmania Version number: 2 Effective date: 01/12/2015 Review due:

More information

Pain Management Drug Testing: A Laboratory Perspective

Pain Management Drug Testing: A Laboratory Perspective Ernest Jimenez III, M.T.(ASCP) Nothing to declare. Laboratory manager at Pharos Diagnostics, LLC., located in Tucson, AZ. Pain Management Drug Testing: A Laboratory Perspective 1 2 Pain Management Drug

More information

Drug Testing Technologies: Sweat Patch

Drug Testing Technologies: Sweat Patch Drug Testing Technologies: Sweat Patch A recent innovation in the science of drug testing, the PharmChek Drugs of Abuse Patch - or "sweat patch" - is used to test for various illegal drugs. The sweat patch

More information

Keywords: albuminuria; albumin/creatinine ratio (ACR); measurements. Introduction

Keywords: albuminuria; albumin/creatinine ratio (ACR); measurements. Introduction Clin Chem Lab Med 2015; 53(11): 1737 1743 Beryl E. Jacobson, David W. Seccombe*, Alex Katayev and Adeera Levin A study examining the bias of albumin and albumin/creatinine ratio measurements in urine DOI

More information

25 OH Vitamin D Rapid Test

25 OH Vitamin D Rapid Test INSTRUCTION FOR USE REF:GDB 7120-25T 25 OH Vitamin D Rapid Test A Rapid Sandwich Immunochromatographic Test for Quantitative Detection of total 25-OH Vitamin D in human finger-prick blood For In Vitro

More information

Supporting Information. Prolonged exposure to bisphenol A from single dermal contact events

Supporting Information. Prolonged exposure to bisphenol A from single dermal contact events Supporting Information Prolonged exposure to bisphenol A from single dermal contact events Jiaying Liu, Jonathan W. Martin Table of Contents Table S1. Table S2. Figure S1. Figure S2. Figure S3. Figure

More information

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases Clinical, Forensic & Toxicology Applications Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases By Shun-Hsin

More information

A brief history of urine drug testing. Forging a common vocabulary for urine drug testing

A brief history of urine drug testing. Forging a common vocabulary for urine drug testing A brief history of urine drug testing Forging a common vocabulary for urine drug testing Gary M. Reisfield, M.D. Assistant Professor and Director Division of Pain and Palliative Medicine Department of

More information

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical

More information

Rapid Alcohol Screening Devices. p19

Rapid Alcohol Screening Devices. p19 CLIA-WAIVED Product Catalog RAPID DRUG SCREENING DEVICES Rapid Urine Drug Screening Devices. p5 Rapid Alcohol Screening Devices. p19 Complementary Products. p23 HELPING YOU MAKE INFORMED DECISIONS ABOUT

More information

SCIEX Vitamin D 200M Assay for the Topaz System

SCIEX Vitamin D 200M Assay for the Topaz System The First FDA-Cleared LC-MS/MS Assay for Vitamin D SCIEX Vitamin D 200M Assay for the Topaz System The first FDA-cleared LC-MS/MS assay for Vitamin D Vitamin D is an important building block for human

More information

ALCOHOLIC BEVERAGES AND ALCOHOL CONSUMPTION

ALCOHOLIC BEVERAGES AND ALCOHOL CONSUMPTION ALCOHOLIC BEVERAGES AND ALCOHOL CONSUMPTION prof. Maurizio Minelli I.I.S. «Arrigo Serpieri» Bologna - Italy ALCOHOLIC BEVERAGES AND ALCOHOL CONSUMPTION Alcoholic beverages and alcohol consumption: an overview.

More information

Recent Advances in the Analysis of Ethanol in Saliva: Evaluation of the QED Device

Recent Advances in the Analysis of Ethanol in Saliva: Evaluation of the QED Device Recent Advances in the Analysis of Ethanol in Saliva: Evaluation of the QED Device A.W. Jones and k A. Jünsson Departments of Alcohol Toxicology and Internal Medicine, University Hospital, 581 85 Linköping,

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall

More information

Oxalate (urine, plasma)

Oxalate (urine, plasma) Oxalate (urine, plasma) 1 Name and description of analyte 1.1 Name of analyte Oxalate 1.2 Alternative names 1.3 NLMC code To follow 1.4. Function of analyte Oxalate is a metabolic end product primarily

More information

Abbreviations and Terms You Should Know

Abbreviations and Terms You Should Know Abbreviations and Terms You Should Know Abbreviations ASD BAT CDL CMV DER DOT EBT HHS MRO NHTSA Alcohol Screening Device Breath Alcohol Technician Commercial Driver s License Commercial Motor Vehicle Designated

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Elevated Urine Zinc Concentration Reduces the Detection of Methamphetamine, Cocaine, THC and Opiates in Urine by EMIT

Elevated Urine Zinc Concentration Reduces the Detection of Methamphetamine, Cocaine, THC and Opiates in Urine by EMIT Journal of Analytical Toxicology 2013;37:665 669 doi:10.1093/jat/bkt056 Advance Access publication July 10, 2013 Article Elevated Urine Zinc Concentration Reduces the Detection of Methamphetamine, Cocaine,

More information

EDUCATIONAL COMMENTARY METHADONE

EDUCATIONAL COMMENTARY METHADONE EDUCATIONAL COMMENTARY METHADONE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits see the Continuing Education

More information

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine High-Throughput Quantitative LC-MS/MS Analysis of and 14 Benzodiazepines in Urine Bill Yu, Kristine Van Natta, Marta Kozak, Thermo Fisher Scientific, San Jose, CA Application Note 588 Key Words Opiates,

More information

OneStep Methadone Urine RapiCard InstaTest. Cat. #

OneStep Methadone Urine RapiCard InstaTest. Cat. # CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label Σ=25

More information